Scholarlink

<p>This study evaluated the safe apnea time in patients at moderate high altitude and the effect of combining a nasopharyngeal airway. Thirty-six patients were randomly assigned to either a preoxygenation group (Group P) or a nasopharyngeal airway group (Group N).<b>P Group</b>: Standard facemask preoxygenation was followed by intravenous induction with maintenance guided by bispectral index (BIS) monitoring (40–60);<b>N Group</b>: Building upon the P group protocol, a nasopharyngeal airway delivering 12&#xa0;L/min pure oxygen for apneic oxygenation was inserted prior to laryngoscopy The primary outcome was the safe apnea time in both groups. Secondary outcomes included the maximum PetCO₂ after resumption of ventilation, hemodynamic parameters, and others.The results demonstrated that the safe apnea time in Group P was 506 (399–613) s, whereas in Group N it was prolonged to 732 (492–900) s. No significant hemodynamic differences were observed between the groups. Following resumption of ventilation, Group N exhibited a lower PetCO₂ and higher PaO₂ on arterial blood gas analysis at T3.Preoxygenation combined with apneic oxygenation via a nasopharyngeal airway extends the safeapnea time without causing adverse hemodynamic effects, offering a clinically feasible strategy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nasopharyngeal airway oxygenation enhances safe apnea time in patients at moderately high altitude: a randomized clinical trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月9日

查看全文
  • Huixing Liu,
  • Yeyue Gao,
  • Yaojun Lu,
  • Wangjun Dong,
  • Shen Sun,
  • Chen Yang

摘要

This study evaluated the safe apnea time in patients at moderate high altitude and the effect of combining a nasopharyngeal airway. Thirty-six patients were randomly assigned to either a preoxygenation group (Group P) or a nasopharyngeal airway group (Group N).P Group: Standard facemask preoxygenation was followed by intravenous induction with maintenance guided by bispectral index (BIS) monitoring (40–60);N Group: Building upon the P group protocol, a nasopharyngeal airway delivering 12 L/min pure oxygen for apneic oxygenation was inserted prior to laryngoscopy The primary outcome was the safe apnea time in both groups. Secondary outcomes included the maximum PetCO₂ after resumption of ventilation, hemodynamic parameters, and others.The results demonstrated that the safe apnea time in Group P was 506 (399–613) s, whereas in Group N it was prolonged to 732 (492–900) s. No significant hemodynamic differences were observed between the groups. Following resumption of ventilation, Group N exhibited a lower PetCO₂ and higher PaO₂ on arterial blood gas analysis at T3.Preoxygenation combined with apneic oxygenation via a nasopharyngeal airway extends the safeapnea time without causing adverse hemodynamic effects, offering a clinically feasible strategy.